Diagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: A systematic review and meta-analysis

European Journal of Radiology

Volumn 95, Issue , 2017, Pages 46-55

  Woo, Sungmin ^a   Suh, Chong Hyun ^b,c   Kim, Sang Youn ^a   Cho, Jeong Yeon ^a   Kim, Seung Hyup ^a  

^a Seoul National University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Namwon Medical Center   (South Korea)

Author keywords

Bladder cancer; Local staging; Magnetic resonance imaging; Meta analysis; Muscle invasive bladder cancer; Systematic review

Indexed keywords

ARTICLE; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC PERFORMANCE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; META ANALYSIS; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; MUSCLE INVASIVE BLADDER CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ADULT; AGED; BLADDER TUMOR; MIDDLE AGED; MUSCLE TUMOR; STANDARDS; TUMOR INVASION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MUSCLE NEOPLASMS; NEOPLASM INVASIVENESS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 85026769006     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2017.07.021     Document Type: Article

References (37)

1. Josephson, D., Pasin, E., Stein, J.P., Superficial bladder cancer: part 2. Management. Expert Rev. Anticancer Ther. 7 (2007), 567–581.
2. Hautmann, R.E., Abol-Enein, H., Hafez, K., et al. Urinary diversion. Urology 69 (2007), 17–49.
3. Rosenkrantz, A.B., Haghighi, M., Horn, J., et al. Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: preliminary results. Am. J. Roentgenol. 201 (2013), 1254–1259.
4. Daneshmand, S., Ahmadi, H., Huynh, L.N., Dobos, N., Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. Urology 80 (2012), 1313–1318.
5. Wang, H.J., Pui, M.H., Guan, J., et al. Comparison of early submucosal enhancement and tumor stalk in staging bladder urothelial carcinoma. Am. J. Roentgenol.(August), 2016, 1–7 (Epub ahead of print).
6. Babjuk, M., Bohle, A., Burger, M., et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur. Urol. 71 (2017), 447–461.
7. Alfred Witjes, J., Lebret, T., Comperat, E.M., et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur. Urol. 71:2017 (2016), 462–475.
8. Liberati, A., Altman, D.G., Tetzlaff, J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J. Clin. Epidemiol 62 (2009), e1–e34.
9. Whiting, P.F., Rutjes, A.W., Westwood, M.E., et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Int. Med. 155 (2011), 529–536.
10. Suh, C.H., Park, S.H., Successful publication of systematic review and meta-analysis of studies evaluating diagnostic test accuracy. Korean J. Radiol. 17 (2016), 5–6.
11. Lee, J., Kim, K.W., Choi, S.H., Huh, J., Park, S.H., Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-Part II. Statistical methods of meta-analysis. Korean J. Radiol. 16 (2015), 1188–1196.
12. Deeks, J.J., Macaskill, P., Irwig, L., The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J. Clin. Epidemiol. 58 (2005), 882–893.
13. J. Higgins, S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. http://handbook.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm. Updated March 2011. (Accessed 3 January 2017).
14. Abdel-Rahman, H.M., El Fiki, I.M., Desoky, E.A., Elsayed, E.R., Samad, K.M.A., The role of diffusion-weighted magnetic resonance imaging in T staging and grading of urinary bladder cancer. Egypt. J. Radiol. Nucl. Med. 46 (2015), 741–747.
15. Afifi, A.H., Maksoud, T.A.S.A., EL-noueam, K.I., Ataa, M.A., Abdallah, D.M., Multiparametric-MRI as a comprehensive study in evaluation, characterization & local staging of urinary bladder carcinomas. Egypt. J. Radiol. Nucl. Med. 48 (2017), 493–507.
16. Ghafoori, M., Shakiba, M., Ghiasi, A., Asvadi, N., Hosseini, K., Alavi, M., Value of MRI in local staging of bladder cancer. Urol. J. 10 (2013), 866–872.
17. Hayashi, N., Tochigi, H., Shiraishi, T., Takeda, K., Kawamura, J., A new staging criterion for bladder carcinoma using gadolinium-enhanced magnetic resonance imaging with an endorectal surface coil: a comparison with ultrasonography. BJU Int. 85 (2000), 32–36.
18. Kobayashi, S., Koga, F., Yoshida, S., et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur. Radiol. 21 (2011), 2178–2186.
19. Lee, M., Shin, S.J., Oh, Y.T., et al. Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion. Eur. Radiol.(February), 2017 (Epub ahead of print).
20. Lista, F., Andres, G., Caceres, F., Ramon de Fata, F., Rodriguez-Barbero, J.M., Angulo, J.C., Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy. Actas. Urol. Esp. 37 (2013), 419–424.
21. Mizuno, K., Sasaki, T., Saito, Y., et al. Gadolinium-enhanced MR imaging T2-weighted MR imaging, and transurethral ultrasonography. Nippon Acta Radiol. 61 (2001), 496–501.
22. Nishimura, K., Fujiyama, C., Nakashima, K., Satoh, Y., Tokuda, Y., Uozumi, J., The effects of neoadjuvant chemotherapy and chemo-radiation therapy on MRI staging in invasive bladder cancer: comparative study based on the pathological examination of whole layer bladder wall. Int. Urol. Nephrol. 41 (2009), 869–875.
23. Ohgiya, Y., Suyama, J., Sai, S., et al. Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T. Magn. Reson. Med. Sci. 13 (2014), 175–181.
24. Panebianco, V., De Berardinis, E., Barchetti, G., et al. An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer. Eur. Radiol.(February), 2017 (Epub ahead of print).
25. Rabie, E., Faeghi, F., Izadpanahi, M.H., Dayani, M.A., Role of dynamic contrast-enhanced magnetic resonance imaging in staging of bladder cancer. J. Clin. Diagn. Res., 10, 2016 TC 01–05.
26. Rajesh, A., Sokhi, H., Fung, R., Mulcahy, K., Bankart, M., Bladder cancer: evaluation of staging accuracy using dynamic MRI. Clin. Radiol. 66 (2011), 1140–1145.
27. Sevcenco, S., Ponhold, L., Heinz-Peer, G., et al. Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness. Urol. Oncol. 32 (2014), 1166–1171.
28. Sherif, M.F., The value of diffusion weighted MR imaging in T staging and correlation with histologic grading in urinary bladder cancer. Egypt. J. Radiol. Nucl. Med. 46 (2015), 189–194.
29. Stojovska-Jovanovska, E., Mitreska, N., Stojovski, M., Lazarova, A., Stavridis, S., Dodevski, A., Computed tomography or magnetic resonance imaging – our experiences in determining preoperative TNM staging of bladder cancer. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 34 (2013), 63–70.
30. Takeuchi, M., Sasaki, S., Ito, M., et al. Urinary bladder cancer: diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade. Radiology 251 (2009), 112–121.
31. Tillou, X., Grardel, E., Fourmarier, M., et al. Can MRI be used to distinguish between superficial and invasive transitional cell bladder cancer?. Prog. Urol. 18 (2008), 440–444.
32. Watanabe, H., Kanematsu, M., Kondo, H., et al. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value. Am. J. Roentgenol. 192 (2009), 1361–1366.
33. Wu, L.M., Chen, X.X., Xu, J.R., et al. Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI. Acad. Radiol. 20 (2013), 939–946.
34. Yamada, Y., Kobayashi, S., Isoshima, S., Arima, K., Sakuma, H., Sugimura, Y., The usefulness of diffusion-weighted magnetic resonance imaging in bladder cancer staging and functional analysis. J. Cancer Res. Ther. 10 (2014), 878–882.
35. Zhai, N., Wang, Y.H., Zhu, L.M., et al. Sensitivity and specificity of diffusion-weighted magnetic resonance imaging in diagnosis of bladder cancers. Clin. Invest. Med. 38 (2015), E173–184.
36. Woo, S., Kim, S.Y., Cho, J.Y., Kim, S.H., Assessment of deep myometrial invasion of endometrial cancer on MRI: added value of second-opinion interpretations by radiologists subspecialized in gynaecologic oncology. Eur. Radiol. 27 (2017), 1877–1882.
37. Wibmer, A., Vargas, H.A., Donahue, T.F., et al. Diagnosis of extracapsular extension of prostate cancer on prostate MRI: impact of second-opinion readings by subspecialized genitourinary oncologic radiologists. Am. J. Roentgenol. 205 (2015), W73–78.